Last Updated: October 16, 2026

Claims for Patent: 9,102,731

✉ Email this page to a colleague

Summary for Patent: 9,102,731

Title:	Human CGRP receptor binding proteins
Abstract:	Antigen binding proteins that bind to human CGRP receptor (CGRP R) are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same are also provided. The antigen binding proteins can inhibit binding of CGRP R to CGRP, and are useful in a number of CGRP R related disorders, including the treatment and/or prevention of migraine headaches.
Inventor(s):	Boone Thomas C., Brankow David W., Gegg, Jr. Colin V., Hu Shaw-Fen Sylvia, King Chadwick T., Lu Hsieng Sen, Shi Licheng, Xu Cen
Assignee:	AMGEN INC.
Application Number:	US12642711
Patent Claims:

Details for Patent 9,102,731

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Amgen Inc.	AIMOVIG	erenumab-aooe	Injection	761077	May 17, 2018	9,102,731	2029-12-18
Amgen Inc.	AIMOVIG	erenumab-aooe	Injection	761077	March 11, 2019	9,102,731	2029-12-18
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,102,731

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	201105418	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2010075238	⤷ Start Trial
United States of America	12122841	⤷ Start Trial
United States of America	12134652	⤷ Start Trial
United States of America	2010172895	⤷ Start Trial
United States of America	2013071410	⤷ Start Trial
United States of America	2015376286	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.